Vuzix [VUZI] vs Zepp Health [ZEPP] Detailed Stock Comparison

Vuzix Corporation

NASDAQ
Loading...

Zepp Health Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Vuzix Corporation wins in 6 metrics, Zepp Health Corporation wins in 12 metrics, with 0 ties. Zepp Health Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vuzix Corporation Zepp Health Corporation Better
P/E Ratio (TTM) -5.87 -6.56 Vuzix Corporation
Price-to-Book Ratio 7.86 1.20 Zepp Health Corporation
Debt-to-Equity Ratio 2.89 54.21 Vuzix Corporation
PEG Ratio 0.23 0.09 Zepp Health Corporation
EV/EBITDA -6.42 -175.77 Vuzix Corporation
Profit Margin (TTM) -16.92% -15.48% Zepp Health Corporation
Operating Margin (TTM) -369.00% -4.55% Zepp Health Corporation
Return on Equity -89.68% -17.15% Zepp Health Corporation
Return on Assets (TTM) -50.92% -3.34% Zepp Health Corporation
Free Cash Flow (TTM) $-21.36M $-25.88M Vuzix Corporation
1-Year Return 5.76% 103.03% Zepp Health Corporation
Price-to-Sales Ratio (TTM) 31.64 0.91 Zepp Health Corporation
Enterprise Value $188.60M $4.26B Zepp Health Corporation
EV/Revenue Ratio 30.03 16.44 Zepp Health Corporation
Gross Profit Margin (TTM) 16.74% N/A N/A
Revenue per Share (TTM) $0 $16 Zepp Health Corporation
Earnings per Share (Diluted) $-0.42 $-2.56 Vuzix Corporation
Beta (Stock Volatility) 1.37 1.77 Vuzix Corporation
Short % of Float 20.31% 7.68% Zepp Health Corporation

Vuzix Corporation vs Zepp Health Corporation Stock Performance Analysis

Loading Price Chart...

VUZI
ZEPP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vuzix Corporation8.97%-0.29%13.33%61.14%25.46%-11.69%
Zepp Health Corporation7.46%-18.45%-50.83%-68.93%-82.20%-82.02%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vuzix Corporation5.76%-40.12%-80.19%-53.43%-53.78%-75.53%
Zepp Health Corporation103.03%0.21%-89.23%-89.70%-89.70%-89.70%

Performance & Financial Health Analysis: Vuzix Corporation vs Zepp Health Corporation

MetricVUZIZEPP
Market Information
Market Cap i$205.40M$245.12M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i787,02955,852
90 Day Avg. Volume i926,886108,171
Last Close$3.40$5.04
52 Week Range$1.83 - $5.62$2.25 - $61.85
% from 52W High-39.50%-91.85%
All-Time High$32.43 (Apr 05, 2021)$81.00 (Feb 15, 2021)
% from All-Time High-89.52%-93.78%
Growth Metrics
Quarterly Revenue Growth0.76%0.43%
Quarterly Earnings Growth0.76%N/A
Financial Health
Profit Margin (TTM) i-0.17%-0.15%
Operating Margin (TTM) i-3.69%-0.05%
Return on Equity (TTM) i-0.90%-0.17%
Debt to Equity (MRQ) i2.8954.21
Cash & Liquidity
Book Value per Share (MRQ)$0.30$13.51
Cash per Share (MRQ)$0.25$0.23
Operating Cash Flow (TTM) i$-18,789,272$-25,970,000
Levered Free Cash Flow (TTM) i$-9,064,530$-116,647,485
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Vuzix Corporation vs Zepp Health Corporation

MetricVUZI (Apr 26, 2026)ZEPP (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-5.87-6.56
Forward P/E i-5.69231.14
PEG Ratio i0.230.09
Price to Sales (TTM) i31.640.91
Price to Book (MRQ) i7.861.20
Market Capitalization
Market Capitalization i$205.40M$245.12M
Enterprise Value i$188.60M$4.26B
Enterprise Value Metrics
Enterprise to Revenue i30.0316.44
Enterprise to EBITDA i-6.42-175.77
Risk & Other Metrics
Beta i1.371.77
Book Value per Share (MRQ) i$0.30$13.51

Financial Statements Comparison: Vuzix Corporation vs Zepp Health Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVUZI (2025)ZEPP (2025)
Revenue/Sales i6.28MN/A
Cost of Goods Sold i7.34MN/A
COGS % of Revenue i116.9%-
Gross Profit i-1.06MN/A
Gross Margin i-16.9%-
Research & Development i12.63MN/A
Operating Income (EBIT) i-32.38MN/A
Operating Margin i-515.5%-
EBITDA i-29.33MN/A
EBITDA Margin i-467.0%-
Pre-Tax Income i-32.27MN/A
Pre-Tax Income % of Revenue i-513.9%-
Income Tax i0N/A
Income Tax % of Revenue i0.0%-
Net Income (Profit) i-32.27MN/A
Profit Margin i-513.9%-

Balance Sheet & Liquidity Metrics

MetricVUZI (2025)ZEPP (2025)
Cash & Equivalents i21.15M91.07M
Total Current Assets i27.20M251.56M
Total Current Assets % of Revenue i433.0%-
Total Current Liabilities i4.89M195.37M
Total Current Liabilities % of Revenue i77.8%-
Long-Term Debt i502,11477.25M
Long-Term Debt % of Revenue i8.0%-
Total Shareholders Equity i34.68M252.73M
Retained Earnings i-399.86M28.62M
Retained Earnings % of Revenue i-6,366.6%-
Property, Plant & Equipment i11.35M3.46M

Cash Flow Statement Comparison

MetricVUZI (2025)ZEPP (2025)
Operating Cash Flow i-21.85M-25.97M
Operating Cash Flow % of Revenue i-347.8%-
Capital Expenditures i-2.01M-707,000
Free Cash Flow i-21.36M-25.88M
FCF Margin i-340.1%-
Debt Repayment iN/A-12.60M
Common Stock Repurchase i0-2.28M

Short Interest & Institutional Ownership Analysis

MetricVUZIZEPP
Shares Short i15.89M463,069
Short Ratio i16.174.16
Short % of Float i20.31%7.68%
Shares Outstanding i81.10M7.04M
Float Shares i70.78M96.40M
% Held by Insiders i15.82%7.64%
% Held by Institutions i35.45%63.11%
% Held by Public i48.73%29.25%

Dividend Analysis & Yield Comparison: Vuzix Corporation vs Zepp Health Corporation

MetricVUZIZEPP
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A